UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating
In a report published Monday, Bank of America Merrill Lynch initiated coverage on Mylan (NASDAQ: MYL) with an Overweight rating.
BofA Merrill Lynch noted, “We initiate coverage on Mylan at OW-100%, as we see material yield and promising long-term growth prospects vs. peers within the IG Pharma subsector. Moody's and S&P upgraded Mylan to investment grade last week mainly due to its strong positioning in the generics market and favorable financial policies.”
Mylan closed on Friday at $27.11.
Latest Ratings for MYL
|Apr 2015||CRT Capital||Maintains||Buy|
|Apr 2015||BMO Capital||Upgrades||Underperform||Market Perform|
|Apr 2015||Deutsche Bank||Maintains||Buy|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.